Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erbium Laser vs. DNA Repair Enzymes for p53 Expression
NCT04277949Unknown
- Sponsor
- Moy-Fincher-Chipps Facial Plastics and Dermatology
- Start
- Apr 2020
- Primary completion
- Jun 2020
- Modality
- Therapeutic Enzymes
01
Overview
Open-label trial of UV endonuclease from Micrococcus luteus in photodamage (2 arms), sponsored by Moy-Fincher-Chipps Facial Plastics and Dermatology. Primary endpoint: p53 epidermal expression at 3 months. Status: unknown.
02
Drugs
UV endonuclease from Micrococcus luteus
03
Conditions
photodamage
Beyond the preview
Go deeper on NCT04277949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04277949.